WHO ICTRP trial
The combination therapy of pemetrexed and continued EGFR-TKIs beyond disease…
JPRN-UMIN000010935 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000010935 |
|---|---|
| Public title | The combination therapy of pemetrexed and continued EGFR-TKIs beyond disease progression to first-line EGFR-TKIs treatments in elderly patients with advanced non-small-cell lung cancer harboring EGFR mutations: a phase 2 trial. |
| Scientific title | The combination therapy of pemetrexed and continued EGFR-TKIs beyond disease progression to first-line EGFR-TKIs treatments in elderly patients with advanced non-small-cell lung cancer harboring EGFR mutations: a phase 2 trial. - Pemetrexed and continued EGFR-TKIs beyond progressive disease in… |
| Primary sponsor | Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | non-small-cell lung cancer |
| Interventions | The combination therapy of pemetrexed and continued EGFR-TKIs in elderly patients with EGFR-mutant advanced NSCLC that has developed acquired resistance to EGFR-TKIs is assessed. |
| Registration date | Dec 6, 2013 |
| Target size | 22 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: